What Is Oculopalatal Myoclonus?

Oculopalatal myoclonus (OPM), also known as ocular palatal myoclonus, is a rare movement disorder defined by involuntary, rhythmic contractions of the soft palate accompanied by oscillating eye movements. The condition typically appears weeks to months after damage to the brainstem or cerebellum, and it reflects an abnormal interaction between deep brain structures that normally coordinate motor control.

Clinical Features

The central finding is a continuous, rhythmic palatal movement that may be visible as an upward and downward motion of the soft palate. Many patients are not consciously aware of this movement, although some report a clicking or fluttering sensation in the ear. The eye movement component takes the form of nystagmus, usually with a pendular, back-and-forth pattern rather than the quick and slow phases seen in other forms of nystagmus. This nystagmus is often vertical or torsional and may be the most disabling feature because it causes the visual world to appear to bounce or sway, a symptom called oscillopsia.

Pathophysiology

OPM is most closely linked to injury involving a functional circuit known as the Guillain-Mollaret triangle. This triangle connects the dentate nucleus of the cerebellum, the red nucleus, and the inferior olivary nucleus. When one of these pathways is disrupted, the inferior olive can undergo a distinctive process called hypertrophic olivary degeneration. Over time, the olive becomes enlarged and discharges rhythmically, driving the synchronized palatal movement and nystagmus that define OPM.

Diagnosis

Diagnosis is primarily clinical. The combination of rhythmic palatal movement and pendular nystagmus is highly characteristic. Imaging with magnetic resonance imaging may reveal enlargement and abnormal signal in the inferior olive, which helps confirm the diagnosis. In selected cases, electrophysiological studies can document the rhythmic discharges and distinguish OPM from other movement disorders.

Treatment and Prognosis

There is no cure for OPM, but treatment is aimed at reducing symptoms. Oral agents such as clonazepam, valproate, memantine, or trihexyphenidyl may lessen the amplitude or frequency of palatal movement and nystagmus in some patients. Botulinum toxin injections into the palatal muscles can reduce palatal movement and the associated clicking sensation, although they generally do not resolve the ocular component. The underlying lesion is usually static, and OPM is not life-threatening, but the visual disturbance can significantly affect daily life. A multidisciplinary approach involving neuromedicine, ophthalmology, and rehabilitation can be helpful for symptom management and adaptation.